Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes
Rx Milk
Rx Milk: Donor Milk Supplementation to Increase Breastfeeding Duration & Exclusivity, a Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is a randomized controlled trial seeking to determine whether supplementing infants at risk for excessive neonatal weight loss with a small volume of human donor milk prophylactically in the first 1-3 days of life, before maternal mature milk production (before mom's milk "comes in") will decrease the incidence of formula use at 1 week and 1, 2, and 3 months of life and increase the rate of exclusive breastfeeding in this high-risk population. We hypothesize that supplementation of term infants who have lost greater than or equal to 5% birth weight by 36 hours of age with a small volume of donor breast milk following feeds, until mature milk production, will result in decreased supplemental formula use at 1 week and increased exclusive as well as any breastfeeding at 1 week and 1, 2, and 3 months. This study's specific aims are to compare the effectiveness of encouraging in-hospital exclusive breastfeeding with offering early small-volume donor milk supplementation in a population of infants at risk for excessive neonatal weight loss with goals of 1) decreasing the incidence of formula supplementation at 1 week of life and 2) improving breastfeeding duration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 18, 2014
CompletedFirst Posted
Study publicly available on registry
August 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedMarch 16, 2018
March 1, 2018
2 years
August 18, 2014
March 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Any formula use at 1 week of age
Any formula intake within the last 24 hours.
1 week
Secondary Outcomes (7)
Exclusive breastfeeding
3 months
Any breastfeeding at 3 months
3 months
Any breastfeeding
1 month
Exclusive breastfeeding
1 month
Exclusive breastfeeding
2 months
- +2 more secondary outcomes
Study Arms (2)
Exclusive breastfeeding
NO INTERVENTIONInfants in the exclusive breastfeeding group will continue to breastfeed.
Donor Milk
ACTIVE COMPARATORInfants in this arm will continue to breastfeed and will be given 10 ml of donor breast milk by syringe after each breastfeeding until their mother's milk "comes in." (until the onset of lactogenesis II)
Interventions
breastfeeding plus 10 ml of donor milk by syringe after each breastfeeding until mother's milk "comes in."
Eligibility Criteria
You may qualify if:
- Gestational age greater than or equal to 37 weeks
- Weight loss greater than or equal to 5% (rounded to nearest whole percent) of birth weight in the first 36 hours after birth
- Chronologic age of 24-48 hours old at the time of study enrollment
You may not qualify if:
- twins and higher level multiples
- infant has congenital or chromosomal anomalies that may affect feeding, diagnosed prior to study enrollment
- mother incarcerated
- mother's age \<18 years
- mother reports mature milk production prior to study enrollment
- mother does not speak English
- infants offered \> 1 supplemental feeding of formula or donor milk
- weight loss greater than 10%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laura Kairlead
- Children's Miracle Networkcollaborator
- The Gerber Foundationcollaborator
Study Sites (1)
University of Iowa Children's Hospital
Iowa City, Iowa, 52242, United States
Related Publications (4)
Flaherman VJ, Aby J, Burgos AE, Lee KA, Cabana MD, Newman TB. Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT. Pediatrics. 2013 Jun;131(6):1059-65. doi: 10.1542/peds.2012-2809. Epub 2013 May 13.
PMID: 23669513BACKGROUNDFlaherman VJ, Kuzniewicz MW, Li S, Walsh E, McCulloch CE, Newman TB. First-day weight loss predicts eventual weight nadir for breastfeeding newborns. Arch Dis Child Fetal Neonatal Ed. 2013 Nov;98(6):F488-92. doi: 10.1136/archdischild-2012-303076. Epub 2013 Jul 17.
PMID: 23864443BACKGROUNDFlaherman VJ, Bokser S, Newman TB. First-day newborn weight loss predicts in-hospital weight nadir for breastfeeding infants. Breastfeed Med. 2010 Aug;5(4):165-8. doi: 10.1089/bfm.2009.0047.
PMID: 20113202BACKGROUNDKair LR, Flaherman VJ, Colaizy TT. Effect of Donor Milk Supplementation on Breastfeeding Outcomes in Term Newborns: A Randomized Controlled Trial. Clin Pediatr (Phila). 2019 May;58(5):534-540. doi: 10.1177/0009922819826105. Epub 2019 Jan 28.
PMID: 30688082DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura R Kair, MD
University of Iowa
- STUDY DIRECTOR
Tarah T Colaizy, MD, MPH
University of Iowa
- STUDY DIRECTOR
Valerie J Flaherman, MD, MPH
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Adjunct Assistant Professor
Study Record Dates
First Submitted
August 18, 2014
First Posted
August 20, 2014
Study Start
July 1, 2014
Primary Completion
July 1, 2016
Study Completion
September 1, 2016
Last Updated
March 16, 2018
Record last verified: 2018-03